共 32 条
- [21] Inhibition of VEGF receptor-2 (VEGFR-2) signaling prevents portal-systemic collateral (PSC) vessel formation in rats with portal hypertension (PH)JOURNAL OF HEPATOLOGY, 2004, 40 : 4 - 4Fernandez, MMejias, MAngermayr, BGarcia-Pagan, JCRodes, JBosch, J
- [22] Jak2/Arhgef1 signaling correlates with severity of liver disease and represents a target for therapy of portal hypertensionHEPATOLOGY, 2014, 60 : 302A - 302AKlein, SabineRick, JohannaSchierwagen, RobertUschner, Frank E.Strassburg, Christian P.Laleman, WimSauerbruch, TilmanTrebicka, Jonel
- [23] P300 DELETION IN LIVER ENDOTHELIAL CELL ATTENUATES PORTAL HYPERTENSION VIA INHIBITION OF CCL2-MEDIATED ANGIOCRINE SIGNALINGHEPATOLOGY, 2019, 70 : 158A - 158AGao, JinhangKostallari, EnisLiu, MengfeiSehrawat, TejasavHu, XiaoYaqoob, UsmanCao, ShengShah, Vijay
- [25] Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathwayWORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (10)Chen, MinZhao, Jin-BoWu, Guang-BoWu, Zheng-HaoLuo, Gu-QingZhao, Zhi-FengZhang, Chi-HaoLin, Jia-YunLi, Hong-JieQi, Xiao-LiangHuo, Hai-ZhongTuersun, AbudukadierFan, QiangZheng, LeiLuo, Meng
- [26] A nine-strain bacterial consortium improves portal hypertension and insulin signaling and delays non-alcoholic fatty liver disease progression in vivoJOURNAL OF HEPATOLOGY, 2022, 77 : S180 - S180Pinheiro, IrisBarbera, AuroraRaurell, ImmaEstrella, Federicode Leeuw, MarcelBolca, SelinGottardi, DavideHorscroft, NigelPossemiers, SamTeresa Salcedo, MariaGenesca, JoanMartell, MariaAugustin, Salvador
- [27] ENDOTHELIAL MICROPARTICLES FROM VEGF INHIBITOR (VEGFI)-TREATED CANCER PATIENTS MEDIATES ENDOTHELIAL CELL SIGNALING AND ET-1 PRODUCTION: IMPLICATIONS IN VEGFI-INDUCED HYPERTENSIONJOURNAL OF HYPERTENSION, 2018, 36 : E58 - E59Neves, Karla B.Rios, Francisco J.McLeod, MartinHughes, Judith DixonJones, RobertMontezano, Augusto C.Evans, JeffTouyz, Rhian
- [28] Endothelial microparticles from VEGF inhibitors (VEGFi)-treated cancer patients mediate endothelial cells signaling and ET-1 production: implications in VEGFi-induced hypertensionJOURNAL OF HUMAN HYPERTENSION, 2018, 32 (10) : 719 - 719Neves, KarlaRios, FranciscoLopes, RheureMcLeod, MartinHughes, Judith DixonJones, RobertMontezano, AugustoEvans, JeffTouyz, Rhian
- [29] Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle CellsARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (02) : 698 - 710Harrison, Craig B.Trevelin, Silvia CelloneRichards, Daniel A.Santos, Celio X. C.Sawyer, GretaMarkovinovic, AndreaZhang, XiaohongZhang, MinBrewer, Alison C.Yin, XiaokeMayr, ManuelShah, Ajay M.
- [30] Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine SignalingHEPATOLOGY, 2021, 73 (06) : 2468 - 2483Gao, JinhangWei, BoLiu, MengfeiHirsova, PetraSehrawat, Tejasav S.Cao, ShengHu, XiaoXue, FeiYaqoob, UsmanKang, NinglingCui, HuaruiPomerantz, William C. K.Kostallari, EnisShah, Vijay H.